Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. (Q54001348)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. |
scientific article |
Statements
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. (English)
Kushner BH
Cheung NK
Kramer K
Gerald WL
Larson SM
Hameed M
1 January 2001
36
1
194-196